Evidence map›Paper›PMID 41209868›Full record

ArticleCureus2025

Antimicrobial Susceptibility Profile of Klebsiella pneumoniae Isolates From a Tertiary Care Hospital: A Retrospective Study.

Kumudini Panigrahi, Basanti Kumari Pathi, Jyoti Prakash Sahoo

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kumudini PanigrahiMicrobiology, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.
Basanti Kumari PathiMicrobiology, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.
Jyoti Prakash SahooPharmacology, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesGlobally, drug resistance has been growing in number and severity.

methodsThis retrospective study was conducted from October 2022 to September 2024 at Kalinga Institute of Medical Sciences (KIMS), Bhubaneswar, India. We included adult inpatients with positive culture reports for

resultsWe assessed 7,942 different samples in our study. The study population comprised 2,994 (37.70%) females and 4,948 (62.30%) males. The median age was 53.50 (39.75-63.25) years. The majority of samples were obtained from blood (2591, 32.62%), urine (1975, 24.87%), ETT (1887, 23.76%), and body fluid (462, 5.82%). A total of 3,523 (44.36%) participants were hospitalized in ICUs. This study's CAI and HAI cases were 1,541 (19.40%) and 6,401 (80.60%). Among the 7,942

conclusionBlood, urine, and ETT specimens contributed most of the samples. In our study, HAI was four times more common than CAI.

Indexed as

antibiotic sensitivity and resistanceantimicrobial resistanceantimicrobial susceptibility testingbacterial biofilmcommunity-acquired infectionextended spectrum β-lactamasehospital-acquired infectionintensive care unitklebsiella pneumoniae (kp)multidrug-resistant organism (mdro)

Identifiers

PMID41209868
PMCPMC12590189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.